Abiopharma

🔍 M33 Growth I L.P. (Director)

Company: Oncology Institute, Inc. (TOI)

Report Date: 2025-09-04

Detailed Transactions and Holdings:

• Sold 6,018,168 shares of Common Stock at $3.09 per share (Direct)
  Date: 2025-09-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,932,389.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 681,832 shares of Common Stock at $3.09 per share (Direct)
  Date: 2025-09-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 590,892.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
• F2: These securities are held by TOI M, LLC.